Company Description
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada.
The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries.
Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J.
R.
Simplot; Forage Genetics International, LLC; and Bayer AG.
The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.
Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
| Country | United States |
| IPO Date | Nov 10, 2006 |
| Industry | Agricultural Inputs |
| Sector | Basic Materials |
| Employees | 29 |
| CEO | Dr. Oliver P. Peoples Ph.D. |
Contact Details
Address: 19 Presidential Way Woburn, Massachusetts United States | |
| Website | https://www.yield10bio.com |
Stock Details
| Ticker Symbol | YTEN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001121702 |
| CUSIP Number | 98585K862 |
| ISIN Number | US98585K8624 |
| Employer ID | 04-3158289 |
| SIC Code | 3080 |
Key Executives
| Name | Position |
|---|---|
| Dr. Oliver P. Peoples Ph.D. | Co-Founder, President, Chief Executive Officer & Director |
| Charles B. Haaser CPA | Vice President of Finance, Chief Accounting Officer & Treasurer |
| Lynne H. Brum | Vice President of Planning & Corporate Communications and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 06, 2024 | 8-K | Current Report |
| Nov 22, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 16, 2024 | DEFM14A | Filing |
| Oct 03, 2024 | 8-K | Current Report |
| Oct 02, 2024 | PREM14A | Filing |
| Sep 09, 2024 | 8-K | Current Report |
| Aug 20, 2024 | 4 | Filing |
| Aug 19, 2024 | 4 | Filing |